CACLP - The largest IVD Expo & Conference

LumiraDx Gets CE Marks for SARS-CoV-2 Test, COVID-19-Flu Assay

Industry news | 09 June, 2022 | CACLP

Original from: Genomeweb


LumiraDx said on Wednesday that it has received CE marking for a molecular SARS-CoV-2 test and an assay that tests for both SARS-CoV-2 and influenza virus.


The Dual-Target SARS-CoV-2 STAR Complete test detects two gene markers to identify the presence of SARS-CoV-2, according to the company. The LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete assay allows for the simultaneous detection and differentiation of influenza A, influenza B, and SARS-CoV-2. 


Both tests use LumiraDx's qSTAR single-step nucleic acid extraction and amplification technology and run on open RT-PCR instruments. Results are provided within 20 minutes.


Last month, London-based LumiraDx reported an 18 percent increase in first quarter revenues on strong sales of its COVID-19 testing products.


Source: LumiraDx Gets CE Marks for SARS-CoV-2 Test, COVID-19-Flu Assay

Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference